Hearing Information
Notice is hereby further given that the hearing will be held on:
Date & Time Location
August 13, 1998 Room 137B
Thursday State Office Bldg.
10:00 a.m. 141 NW Barstow
WAUKESHA, WI
Notice is hereby further given that pursuant to the Americans with Disabilities Act, reasonable accommodations, including the provision of informational material in an alternative format, will be provided for qualified individuals with disabilities upon request. Please call Todd Peterson at (608) 267-2948 with specific information on your request at least 10 days before the date of the scheduled hearing.
Written Comments and Contact Person
Written comments on the proposed rule may be submitted to
Mr. Todd Peterson
Bureau of Wildlife Management
P.O. Box 7921
Madison, WI 53707
Written comments must be received no later than August 14, 1998, and will have the same weight and effect as oral statements presented at the hearing. A copy of the proposed rule [WM-3-98] and fiscal estimate may be obtained from Mr. Peterson.
Fiscal Estimate
Summary of Rule:
This program was created in the FY97-99 (Fiscal Year 97-99) state budget and has spending authority for $25,000 annually from the wildlife damage surcharge account. The rule authorizes urban communities to receive 50% cost sharing for a variety of wildlife damage and control measures for white-tailed deer and Canada geese. The rule requires that participating communities gather public input on solving their wildlife damage problems, monitor and establish population goals, and describe control methods. The Department will evaluate proposals based on criteria included in the rule.
Fiscal Impact:
There will be some costs associated with establishing and administering the grant program, but it is assumed there will be a small number of grants. The Department can absorb these costs within the existing appropriation.
Utilizing the funding for the grant program will reduce the amount of revenue available for other wildlife damage claims.
Long-Range Fiscal Implications:
None.
Notice of Hearing
Pharmacy Examining Board
Notice is hereby given that pursuant to authority vested in the Pharmacy Examining Board in ss. 15.08 (5) (b), 227.11 (2) and 450.02 (3) (a), (b), (d) and (e), Stats., and interpreting ss. 450.01 (21), 450.11 (1m) and (5), Stats., the Pharmacy Examining Board will hold a public hearing at the time and place indicated below to consider an order to amend ss. Phar 7.01 (1) (a), 8.06 (2) (intro.) and (a) (intro.) and 8.07 (2), 8.09 (1) (intro.), (2) (intro.), (3) and (4); and to create s. Phar 7.08, relating to the transmission and receipt of electronic prescription orders.
Hearing Information
Date & Time Location
August 12, 1998 Room 179A
Wednesday 1400 E. Washington Ave.
9:15 a.m. MADISON, WI
Written Comments
Interested people are invited to present information at the hearing. People appearing may make an oral presentation, but are urged to submit facts, opinions and argument in writing as well. Facts, opinions and argument may also be submitted in writing without a personal appearance by mail addressed to:
Office of Administrative Rules
Dept. of Regulation & Licensing
P.O. Box 8935
Madison, WI 53708
Written comments must be received by August 26, 1998 to be included in the record of rule-making proceedings.
Analysis Prepared by the Dept. of Regulation Licensing
Statutes authorizing promulgation: ss. 15.08 (5) (b), 227.11 (2) and 450.02 (3) (a), (b), (d) and (e)
Statutes interpreted: ss. 450.01 (21), 450.11 (1m) and (5)
The proposed order of the Pharmacy Examining Board is in response to 1997 Wis. Act 27 (the “Act”) which amended several sections of ch. 450, Stats., to specifically authorize the electronic transmission of prescription orders from prescribers to pharmacies. Prior to the new law, the statutes alluded specifically only to oral or written prescription orders. The objective of the proposed rules is to assure the appropriate use of electronic transmission systems in conveying prescription orders, and to provide guidance to the profession in adopting procedures and systems assuring the validity, accuracy and security of prescription orders received electronically from prescribers.
Section 1 amends s. Phar 7.01 (1) (a), to provide that pharmacists are required to review all electronically transmitted prescription orders for therapeutic compatibility and legality, as is currently required for oral and written prescription orders they receive.
Section 2 creates s. Phar 7.08, setting forth the requirements that must be met to authorize a pharmacist to dispense pursuant to an electronically transmitted prescription order. Among these are requirements that the electronic prescription orders must be sent only at the option of the patient and to the pharmacy chosen by the patient; they must contain identifying information regarding the sender and contain language to the effect that the prescription order is being “Electronically Transmitted”; contain all the information required for a valid prescription order under law (e.g., patient name, prescriber name, medication name, directions for use, etc.); and contain either the prescriber's electronic signature or other secure method of validating the order as coming from a prescriber. Additionally, pharmacists are required to adopt measures assuring the security, integrity and confidentiality of the information received by electronic transmission of prescription orders.
Sections 3, 4 and 5 make technical amendments to existing rules consistent with the intent of the Act, by specifically authorizing the renewal of schedule III and IV controlled substance orders by electronic transmission and permitting the emergency and partial dispensing of schedule II controlled substances pursuant to electronically transmitted prescription orders.
Text of Rule
SECTION 1. Phar 7.01 (1) (a) is amended to read:
Phar 7.01 (1) (a) Receive electronic, oral or written prescription orders of a prescriber, review all original and renewal prescription orders, whether electronic, written or oral and determine therapeutic compatibility and legality of the prescription order. The review shall include, when indicated or appropriate, consultation with the prescriber.
SECTION 2. Phar 7.08 is created to read:
Phar 7.08 Prescription orders transmitted electronically. (1) Except as otherwise prohibited by law, prescription orders may be accepted and dispensed if they have been transmitted electronically from a practitioner or his or her designated agent to a pharmacy via computer modem or other similar electronic device. Prescription orders transmitted by facsimile machine are not considered electronic prescription orders; but rather, written prescription orders.
(2) A pharmacist may dispense a prescription pursuant to a prescription order transmitted electronically, if the pharmacist assures the prescription order does all of the following:
(a) Was sent only to the pharmacy of the patient's choice and only at the option of the patient, with no intervening person or third party having access to the prescription order other than to forward it to the pharmacy.
(b) Identifies the individual sender's name and telephone number for oral confirmation, the time and date of transmission, and the pharmacy intended to receive the transmission.
(c) Is designated “electronically transmitted prescription”, or with similar words or abbreviations to that effect.
(d) Contains all other information that is required in a prescription order under law.
(3) The prescribing practitioner's electronic signature, or other secure method of validation shall be provided with the prescription order electronically transmitted via computer modem or other similar electronic device.
(4) Any visual or electronic document received shall only be accessible within the professional service area of the pharmacy to protect patient confidentiality and assure security.
(5) Any pharmacist who receives any prescription order electronically shall ensure the security, integrity and confidentiality of the prescription order and any information contained therein. To maintain the confidentiality of patient records, the electronic system shall have adequate security and system safeguards designed to prevent and detect unauthorized access, modification, or manipulation of patient records. Once the prescription has been dispensed, any alterations in prescription order drug data shall be documented including the identification of the pharmacist responsible for the alteration.
(6) Access to the electronic mail system for the receipt of prescription orders electronically may only be acquired by use of a password or passwords, known only to individuals authorized to access the system.
(7) A pharmacist may not use any electronic device to circumvent his or her responsibilities with regard to documenting, authenticating and verifying prescription orders or in order to circumvent other pharmacy laws.
Note: Prescription orders for schedule II controlled substances may not be transmitted electronically except as emergency orders, subject to the same requirements for oral emergency orders for schedule II controlled substances. See s. 961.38 (1r) and (2), Stats., and s. Phar 8.09.
SECTION 3. Phar 8.06 (2) (intro.) and (2) (a) (intro.) are amended to read:
Phar 8.06 (2) The prescribing practitioner may authorize renewals of schedule III or IV controlled substances on the original prescription order or through a verbal an electronic or oral renewal authorization transmitted to the pharmacist. The following conditions must be met:
(a) The pharmacist obtaining the verbal electronic or oral authorization shall note on the prescription order, medication profile record or readily retrievable and uniformly maintained document the following information:
SECTION 4. Phar 8.07 (2) is amended to read:
Phar 8.07 (2) The partial dispensing of a prescription containing a controlled substance listed in schedule II is permissible, if the pharmacist is unable to supply the full quantity called for in a written or emergency verbal electronic or oral prescription order, and the pharmacist makes a notation of the quantity supplied on the face of the written prescription order or written record of the emergency verbal electronic or oral prescription order. The remaining portion of the prescription may be dispensed within 72 hours of the first partial dispensing. If the remaining portion is not dispensed within the 72 hour period, the pharmacist shall so notify the prescribing individual practitioner. No further quantity may be supplied beyond the 72 hours without a new prescription order.
SECTION 5. Phar 8.09 (1) (intro.), (2) (intro.), (3) and (4) are amended to read:
Phar 8.09 (1) For the purpose of authorizing an electronic or oral prescription order for a schedule II controlled substance, the term “emergency” means those situations in which the prescribing practitioner determines that:
(2) In an emergency a pharmacist may dispense a controlled substance listed in schedule II upon receiving electronic or oral authorization of a practitioner if:
(3) If the practitioner is not known to the pharmacist, the pharmacist shall make a reasonable effort to determine that the electronic or oral authorization came from an authorized practitioner, which may include a call back to the prescribing practitioner using the practitioner's phone number as listed in the telephone directory and other good faith efforts to insure the practitioner's identity.
(4) Within 72 hours 7 days after authorizing an emergency electronic or oral prescription order, the practitioner shall cause a written order for the emergency quantity prescribed to be delivered to the dispensing pharmacist. In addition to conforming to the requirements of s. Phar 8.05, the order shall contain on its face “authorization for emergency dispensing” and the date of the electronic or oral order. The written order may be delivered to the pharmacist in person or by mail, but if delivered by mail it shall be postmarked within the 72 hour 7 day period. Upon receipt, the dispensing pharmacist shall attach this prescription order to the electronic or oral emergency order reduced to writing under sub. (2) (b). The pharmacist shall notify the board or department of regulation and licensing if the practitioner fails to deliver the written order. Failure of the pharmacist to provide notification shall void the authority conferred by this section to dispense without a written order of a practitioner.
Fiscal Estimate
1. The anticipated fiscal effect on the fiscal liability and revenues of any local unit of government of the proposed rule is: $0.00.
2. The projected anticipated state fiscal effect during the current biennium of the proposed rule is: $0.00.
3. The projected net annualized fiscal impact on state funds of the proposed rule is: $0.00.
Initial Regulatory Flexibility Analysis
These proposed rules will be reviewed by the Department through its Small Business Review Advisory Committee to determine whether there will be an economic impact on a substantial number of small businesses, as defined in s. 227.114 (1) (a), Stats.
Copies of Rule and Contact Person
